Connect with us
Pfizer-BioNTech asked for authorization Friday to use their Covid-19 vaccine on 12 to 15-year-olds in the United States, which could mark a crucial next step toward...
“We’ll never have perfect data, and there will always be uncertainty,” said Grace Lee, a professor at Stanford University and chair of the advisory panel’s Covid-19...
But despite the recent media coverage, political takes, and new app launches, it’s not clear what the long-term outlook for vaccine credentials might be. In the...
This week, AstraZeneca released two sets of phase III safety trial results for its Covid-19 vaccine, each showing slightly different efficacy rates. The inconsistency has kicked...
Basic research can provide spectacular returns. But only one player really has the patience to invest in it. Read More
by Blake Farmer, Nashville Public Radio As the speed of Covid vaccinations picks up, so do the reports of doses going to waste. And it’s more...
by Samantha Putterman, PolitiFact “Pfizer and Moderna could share their design with dozens of other pharma companies who stand ready to produce their vaccines and end...
Nearly 10% of U.S. adults are fully vaccinated. Read More
Rodney E. Rohde, Texas State University U.S. Census Bureau, CC BY-ND It may be summer before children under 16 can be vaccinated against COVID-19 in the...
In a report released on February 23, Osterholm and his colleagues calculate that temporarily prioritizing first doses for those over the age of 65 might save as...
Recent Comments